anderogenic alopecia. Androgenic alopecia
Conditions
Interventions
Intervention 1: Intervention group: In the first group, 5% localized minoxidil twice a day, any time 1 cc with a 0.1% finasteride topical form, as SLN, once a day, any time 1 cc. Intervention 2: Contr
Sponsors
Mashhad University of Medical Sciences
Eligibility
Sex/Gender
Male
Age
18 Years to 45 Years
Inclusion criteria
Inclusion criteria: Men with Androgenic Alopecia Based on Hamilton's Criteria. Stage 2-4 Completing the consent form
Exclusion criteria
Exclusion criteria: No endocrine disease (diabetes), thyroid disorders, systemic diseases including lupus, other cases, including arthritis and cicatrisil (associated with scar), history of skin or systemic malignancy, psychiatric disorders, skin disorders Head skulls other than those with AGASerious Cardiovascular Diseases, Kidney Disease, Liver Disease No use of zinc and iron supplements, malnutrition, iron deficiency anemia Non-use of medications leads to hair loss, including anti-hypertensive and anti-inflammatory drugs, NSAIDs No history of alcohol consumption or substance abuse No history of finasteride in the last 6 months and minoxidil in the past month No history of drug hypersensitivity, breast disorders, surgical history for the treatment of hair loss
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The number of hair from short hair in 1 cm square in the area of assessment in the Vertex hairless part. Timepoint: At the beginning of the work and weeks 8, 16 and 24. Method of measurement: Using the computer scan obtained from macrophotography images of the marked area, it is evaluated for hair growth. | — |
Secondary
| Measure | Time frame |
|---|---|
| 1- Evaluation of the frequency of local skin complications including: erythema-burning-itchy-folliculitis-clinical diagnosis by the assessor. Timepoint: At the beginning of the work and weeks 8, 16 and 24. Method of measurement: 1-Measuring erythema and itching and burning with a visual analogue scale and evaluating folliculitis clinically and by assessor.;2. Quality of life assessment. Timepoint: At the beginning of the work and weeks 8, 16 and 24. Method of measurement: 2. Assessing the quality of life ,the basis of the WAA-QOL benchmark. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public Contactsama gharaei
Mashhad University of Medical Sciences
Outcome results
None listed